Regulated gene expression after retroviral vector-mediated delivery of cancer-relevant therapeutic genes.
Günzburg
W H
WH
Institute for Molecular Virology, GSF Centre for Environmental and Health Research, Oberschleissheim, Germany.
Karle
P
P
Mrochen
S
S
Sparmann
G
G
Saller
R
R
Klein
D
D
Uckert
W
W
Salmons
B
B
D050759:Cyclin-Dependent Kinase Inhibitor p21; D016213:Cyclins / Q000235:genetics; D016147:Genes, Tumor Suppressor; D015316:Genetic Therapy; D005822:Genetic Vectors; D006801:Humans; D009369:Neoplasms / Q000628:therapy*; D012190:Retroviridae / Q000235:genetics*; D014409:Tumor Necrosis Factor-alpha / Q000235:genetics
C493956:CDKN1A protein, human; D050759:Cyclin-Dependent Kinase Inhibitor p21; D016213:Cyclins; D014409:Tumor Necrosis Factor-alpha